rqmicro.com Revenue and Competitors
Estimated Revenue & Valuation
- rqmicro.com's estimated annual revenue is currently $2.6M per year.
- rqmicro.com's estimated revenue per employee is $155,000
Employee Data
- rqmicro.com has 17 Employees.
- rqmicro.com grew their employee count by 6% last year.
rqmicro.com Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $81.4M | 375 | 40% | N/A | N/A |
#2 | $16.9M | 109 | 22% | N/A | N/A |
#3 | $156.1M | 120 | -70% | $145M | N/A |
#4 | $2.9M | 37 | -24% | $150M | N/A |
#5 | $1.3M | 17 | 0% | $459.5M | N/A |
#6 | $49.2M | 254 | 15% | $180.7M | N/A |
#7 | $7M | 45 | -2% | N/A | N/A |
#8 | $256.3M | 840 | 9% | $168.5M | N/A |
#9 | $4.2M | 27 | -7% | N/A | N/A |
#10 | $10.1M | 65 | 5% | N/A | N/A |
What Is rqmicro.com?
rqmicro AG, based in Zurich, Switzerland, develops and markets proprietary reagents and innovative instruments for rapid microbiological tests for water and food safety. The new separation and detection technology is based on immunomagnetic separation and microfluidics and delivers accurate results at an unmatched speed. Common methods in microbiology need up to 14 days to give you semi-quantitative data. A waiting time that takes time and money. rqmicro reduces this delay significantly by providing precise quantitative results. With rqmicro instruments you can quantify Legionella in water samples in 1-2 hours.
keywords:N/A
N/A
Total Funding
17
Number of Employees
$2.6M
Revenue (est)
6%
Employee Growth %
N/A
Valuation
N/A
Accelerator
rqmicro.com News
Rqmicro AG (Switzerland). Bactest Ltd. (US). Colifast (Norway). Serosep Ltd. (Ireland). Biosensia (Ireland). Solus Scientific Solutions Ltd.
... rqmicro; Saltro (Acquired by Unilabs); Sartorius Stedim Biotech; SBT Instruments; Sirigen (Acquired by BD); Sony Biotechnology...
Other Companies in Zurich
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $1.4M | 17 | 6% | N/A |
#2 | $2.6M | 17 | -6% | N/A |
#3 | $1.5M | 17 | -11% | N/A |
#4 | $1.7M | 17 | N/A | N/A |
#5 | $1.7M | 17 | -69% | N/A |